Ab&B Bio-Tech CO., LTD. JS (SEHK: 2627)
Health Care · Biotechnology · CN
HK$—
— today · — 1Y
Ab&B Bio-Tech CO., LTD. JS (SEHK: 2627) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.47B and employs 583 people.
trading between 28.88 and 73.00.
Tweenvest scores Ab&B Bio-Tech CO., LTD. JS across four factors: value 90/100. Its strongest factor is value.
2627 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.47B
- Revenue (TTM)
- $45.19M
- P/E
- —
- EPS
- -0.62
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- HK$73.00
- 52-week low
- HK$28.88
- Avg volume (3M)
- —
- Shares outstanding
- 393.44M
- Employees
- 583
- Next earnings
- —
About Ab&B Bio-Tech CO., LTD. JS
Ab&B Bio-Tech Co., Ltd. engages in the research, development, manufacturing and commercialization of innovative and traditional vaccines. Its products include quadrivalent subunit influenza and lyophilized human rabies vaccines. The company was founded by You Cai An on October 28, 2015 and is headquartered in Taizhou, China.
- ISIN
- CNE1000071P9
- Founded
- 2015
- Listed since
- Aug 11, 2025
- Exchange
- The Stock Exchange of Hong Kong Ltd.
- Currency
- HKD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $464.58B | $262.90 | -1.09% |
| Amgen Inc.NasdaqGS: AMGN | $238.06B | $440.34 | -0.43% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $183.64B | $148.09 | -0.01% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.72B | $547.29 | -1.01% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $81.36B | $814.79 | -2.25% |
| argenx SEENXTBR: ARGX | $65.40B | €897.60 | +2.09% |
| Moderna, Inc.NasdaqGS: MRNA | $59.75B | $149.66 | -5.77% |
| CSL LimitedASX: CSL | $59.19B | AU$172.44 | -0.69% |
Figures last refreshed Aug 18, 2026.